Covid Drug Paxlovid Now Less Effective Than In Early Trials—But It’s Still Great At Preventing Death
Paxlovid—Pfizer’s antiviral Covid-19 treatment—is 37% effective at preventing hospitalization or death in high-risk patients compared with no treatment, according to a studypublished Thursday in the JAMA Network Open, well below the 88% effectiveness rate Pfizer and regulators reported in clinical trials in 2021